Taxus Cardium Pharmaceuticals Group Inc (CRXM) - Financial and Strategic SWOT Analysis Review

Taxus Cardium Pharmaceuticals Group Inc (CRXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Taxus Cardium Pharmaceuticals Group Inc (Cardium) is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core gene therapy. Its product portfolio includes FDA approved Excellagen topical gel, a cellular biological skin substitute used for wound care management; and Generx, an interventional cardiology, angiogenic gene therapy product candidate used for the treatment of cardiac microvascular insufficiency. The company also holds non-core interests in the Cell-nique d/b/a Healthy Brands Collective, a health products company, and LifeAgain Insurance Solutions, Inc., an advanced medical data analytics business. Cardium markets its products through third party commercialization partners. The company is headquartered in San Diego, California, the US.

Taxus Cardium Pharmaceuticals Group Inc Key Recent Developments

Dec 14,2016: Taxus Cardium Announces Two Director Retirements Following A Decade Of Distinguished Service

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Taxus Cardium Pharmaceuticals Group Inc - Key Facts 5
Taxus Cardium Pharmaceuticals Group Inc - Key Employees 6
Taxus Cardium Pharmaceuticals Group Inc - Key Employee Biographies 7
Taxus Cardium Pharmaceuticals Group Inc - Major Products and Services 8
Taxus Cardium Pharmaceuticals Group Inc - History 9
Taxus Cardium Pharmaceuticals Group Inc - Company Statement 12
Taxus Cardium Pharmaceuticals Group Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Taxus Cardium Pharmaceuticals Group Inc - Business Description 14
Taxus Cardium Pharmaceuticals Group Inc - Corporate Strategy 15
Taxus Cardium Pharmaceuticals Group Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Taxus Cardium Pharmaceuticals Group Inc - Strengths 16
Taxus Cardium Pharmaceuticals Group Inc - Weaknesses 17
Taxus Cardium Pharmaceuticals Group Inc - Opportunities 18
Taxus Cardium Pharmaceuticals Group Inc - Threats 19
Taxus Cardium Pharmaceuticals Group Inc - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Ratio Charts 25
Section 4 Companys Lifesciences Financial Deals and Alliances 26
Taxus Cardium Pharmaceuticals Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 26
Taxus Cardium Pharmaceuticals Group Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 27
Taxus Cardium Pharmaceuticals Group Inc, Recent Deals Summary 28
Section 5 Companys Recent Developments 29
Dec 14, 2016: Taxus Cardium Announces Two Director Retirements Following A Decade Of Distinguished Service 29
Section 6 Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables


Taxus Cardium Pharmaceuticals Group Inc, Key Facts 5
Taxus Cardium Pharmaceuticals Group Inc, Key Employees 6
Taxus Cardium Pharmaceuticals Group Inc, Key Employee Biographies 7
Taxus Cardium Pharmaceuticals Group Inc, Major Products and Services 8
Taxus Cardium Pharmaceuticals Group Inc, History 9
Taxus Cardium Pharmaceuticals Group Inc, Subsidiaries 13
Taxus Cardium Pharmaceuticals Group Inc, Key Competitors 20
Taxus Cardium Pharmaceuticals Group Inc, Ratios based on current share price 21
Taxus Cardium Pharmaceuticals Group Inc, Annual Ratios 22
Taxus Cardium Pharmaceuticals Group Inc, Annual Ratios (Cont...1) 23
Taxus Cardium Pharmaceuticals Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 26
Taxus Cardium Pharmaceuticals Group Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017 27
Taxus Cardium Pharmaceuticals Group Inc, Recent Deals Summary 28
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List Of Figures


Taxus Cardium Pharmaceuticals Group Inc, Performance Chart (2011 - 2015) 24
Taxus Cardium Pharmaceuticals Group Inc, Ratio Charts 25
Taxus Cardium Pharmaceuticals Group Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 26
Taxus Cardium Pharmaceuticals Group Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 27

Taxus Cardium Pharmaceuticals Group Inc (CRXM) - Medical Equipment - Deals and Alliances Profile

Taxus Cardium Pharmaceuticals Group Inc (Cardium) is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue

USD 250 View Report

Taxus Cardium Pharmaceuticals Group Inc (CRXM) - Medical Equipment - Deals and Alliances Profile

Taxus Cardium Pharmaceuticals Group Inc (Cardium) is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue

USD 250 View Report

Taxus Cardium Pharmaceuticals Group Inc (CRXM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Taxus Cardium Pharmaceuticals Group Inc (Cardium) is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available